刺
胰腺癌
兴奋剂
癌症研究
免疫疗法
癌症
干扰素基因刺激剂
免疫系统
干扰素
细胞毒性
先天免疫系统
医学
癌细胞
免疫学
作者
Yanyan Da,Yuxia Liu,Yuan Hu,Wenzeng Liu,Junpeng Ma,Nan Lü,Chengsheng Zhang,Cai Zhang
出处
期刊:OncoImmunology
[Landes Bioscience]
日期:2022-03-21
卷期号:11 (1): 2054105-2054105
被引量:97
标识
DOI:10.1080/2162402x.2022.2054105
摘要
Activation of the stimulator of interferon gene (STING)-mediated innate immune response has been suggested as a promising therapeutic strategy for cancers. However, the effects of STING agonist on natural killer (NK) cell-mediated anti-tumor responses in pancreatic cancer remains unknown. Herein, we evaluated the effects of a classical STING agonist cyclic GMP-AMP (cGAMP) on NK cells in pancreatic cancer. We found that cGAMP could directly activate NK cells and enhance the sensitivity of pancreatic cancer cells to NK cell cytotoxicity, suggesting that cGAMP may become a potential adjuvant for NK cell therapy. In addition, combination of CAR-NK-92 cells targeting mesothelin and cGAMP displayed greater antitumor efficacy by inhibiting tumor growth and prolonging survival of the mouse model of pancreatic cancer. These results suggest that the combination of a STING agonist and NK cells may become a novel immunotherapy strategy for pancreatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI